The review discusses fifty eight peptides in numerous clinical phases, indicating a strong pipeline of peptide therapies focusing on PPIs. Clinical trials and preclinical studies are highlighted, exhibiting the efficacy of peptide vaccines in inducing an immune reaction, with the possible to enhance survival charges for HCC individuals. By mimicking https://lordl123ggd4.blogdosaga.com/profile